𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N0775

✍ Scribed by Lisa A. Kottschade; Vera J. Suman; Domingo G. Perez; Robert R. McWilliams; Judith S. Kaur; Thomas T. Amatruda III; Francois J. Geoffroy; Howard M. Gross; Peter A. Cohen; Anthony J. Jaslowski; Matthew L. Kosel; Svetomir N. Markovic

Book ID
115554711
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
335 KB
Volume
119
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

PointBreak: A Randomized Phase III Study
PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer
✍ Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Ols πŸ“‚ Article πŸ“… 2013 πŸ› American Society of Clinical Oncology 🌐 English βš– 243 KB
Treatment Rationale and Study Design for
Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
✍ Jyoti D. Patel; Philip Bonomi; Mark A. Socinski; Ramaswamy Govindan; Shengyan Ho πŸ“‚ Article πŸ“… 2009 πŸ› CIG Media Group, LP. 🌐 English βš– 100 KB